We also detected the biological behavior changes and the expression levels of GPR84, KLF7, IL-6, p21 under FFA C8:0 treatment of PCa cells (PC-3/22RV1) in vitro. Our study will provide a molecular target for the prevention and treatment of PCa in the clinic. This evidence concerns the gene GPR84 and posterior cortical atrophy.